Skip to main content

This webpage content is intended for Health Care Professionals (HCPs) only.

I am not a HCP

Intended for Healthcare Professionals

Johnson and Johnson logo graphic link
/en-GB
  • biosense webster logo
  • Cerenovus logo
  • DePuy Synthes Logo
  • Ethicon Logo
  • mentor logo

Intended for HCPs

Intended for Healthcare Professionals

Secondary nav block

biosense webster logo
  • Products
    • All Products
    • 3D Navigation
    • Carto Prime® Mapping
    • Therapeutic Catheters
    • Diagnostic Catheters
    • Ultrasound Solutions
    • Access Products
    • Generators
  • Clinical and Economic Research
    • Clinical Evidence
    • Ongoing Studies
    • External Research Partnerships
    • Health Economics Market Access
  • Resources
    • J&J Institute
    • Medical Information Request (MIR)
  • News
  • About Us
    • Contact Us
  1. Home
  2. HELIOSTAR™ Balloon Ablation Catheter

Biosense Webster 

HELIOSTAR™ Balloon Ablation Catheter

Biosense Webster 

HELIOSTAR™ Balloon Ablation Catheter

The HELIOSTAR™ Balloon Ablation Catheter is fully integrated with the CARTO® 3 System, enabling an efficient, customisable, and low fluoroscopy workflow for PV isolation.*,1,2

Contact us
HELIOSTAR™ Balloon Ablation Catheter

IMAGES

HELIOSTAR™ Balloon Ablation Catheter

Features and Benefits

heliostar balloon ablation catheter

 Customisable Energy Delivery1

  • Automatically titrate energy delivery based on anatomical location1
  • Perform circumferential or segmental ablation1
CARTO® integration

CARTO® integration***,1,6

  • Visualise and navigate the balloon in real- time for potential fluoroscopy reduction5,6,8 
  • Monitor ablation parameters***,1,5
heliostar balloon ablation catheter

Optimal Anatomical Fit1,6

  • Compliant 28 mm balloon1,6
  • Conforms to varied PV anatomy1,6
heliostar balloon ablation catheter

Real-time PVI Validation****,1,5-7

Assess signals during PV isolation1,8
Perform voltage mapping post-ablation7

HELIOSTAR™ Catheter Live Case Demonstration at Boston AF Symposium, 2019

Supporting Documentation

Resources

Order Sheet

View Publication

References

* Based on multicenter single-arm study SHINE (n=95).
** In a multicenter single-arm study, total procedure time was 87.6 ± 22.25 minutes (n = 95, roll-ins = 8 patients. Per protocol, a roll-in phase of up to 3 patients per physician was implemented).
*** When using the HELIOSTAR™ Balloon Ablation Catheter.
**** With the LASSOSTAR™ Catheter.

  1. SHINE Study Clinical Study Report (BWI_2017_01 12M Final Results). December 20, 2019.
  2. Calkins, et al, 2017HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, Europace (2018) 20, e1–e160.
  3. Schilling, R., Dhillon, G., Tondo C., et al. Safety, Effectiveness, and Quality of Life Following Pulmonary Vein Isolation with a Multi-Electrode Radiofrequency Balloon Catheter in Paroxysmal Atrial Fibrillation: One Year Outcomes from SHINE. Europace, 2020. Accepted for formal publication. 
  4. Dhillon, G., Schilling, R. et al. Use of a Multi-Electrode Radiofrequency Balloon Catheter to Achieve Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation: Twelve-month outcomes of the RADIANCE Study. Journal of Electrophysiology, April 2020. doi: 10.1111/jce.14476.
  5. HELIOSTAR™ Balloon Ablation Catheter IFU and Release Notes. UG5450-017. June 2020.
  6. HELIOSTAR™ Balloon Ablation Catheter Instructions for Use. M-5276-1052B.
  7. Biosense Webster, Inc. Internal Design Validation Test Report (TR-0022056, June 27, 2017).
  8. LASSOSTAR™ Circular Mapping Catheter Instructions for Use. M-5276-1005B. 

158952-201112 

© Johnson & Johnson Medical Limited 2021. All Rights Reserved.

This site is published by Biosense Webster, Inc. which is solely responsible for its contents.  This site is for visitors from the United Kingdom and Ireland. 

©Biosense Webster, Inc. 2020  Last Updated on 1/5/20.

biosense webster logo

Johnson & Johnson
Johnson & Johnson
  • 
  • 
  • Privacy Policy
  • Legal Notice
  • Modern Slavery Act Statement
  • Accessibility Statement
  • Contact
  • WEEE Statement
English (United Kingdom & Ireland)

All contents © Medical Devices Business Services, Inc. 2021. All Rights Reserved

ROI

Johnson & Johnson Ireland Ltd is compliant with the Waste Electrical & Electronic Equipment (WEEE) Regulations 2014, with Producer Registration Number: [00541WB].  As a producer we are obligated to offer a takeback service for WEEE, we do this on our own behalf using appropriate recycling facilities. For further information, please contact Johnson & Johnson Ireland Ltd on +353 1 466 5200

 

You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.

Yes, Continue to External Site No, Stay Here